Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

A Wall Street Journal report noted that a prospective deal between Walgreens and New York private-equity firm Sycamore ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...

JP Morgan has recently reduced Progyny Inc (PGNY) stock to Neutral rating, as announced on December 2, 2024, according to Finviz. Earlier, on November 13, 2024, Truist had reduced the stock from a Buy ...

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of BridgeBio Pharma ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...